Real-World Management of Thyroid Cancer with TRK InhibitorsVideo Categories: NTRK Gene Fusions
Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Mary Fidler of Rush University Medical Center, Chicago, IL, recount their clinical experiences and the journeys of patients treated with TRK inhibitors for thyroid cancer.
Which Part of Stem Cells Should Be Treated?
Dr Wainberg and Dr Gerson discuss the ongoing debate about whether clinicians should treat the surface or the internal structure of cancer stem cells.
Occurrence of TRK Fusionâ€“Positive Tumors in Different Cancer Types
Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, confer on the categorization of various cancer types in which NTRK gene fusions may be detected.